This move by Amedica, a spinal and orthopaedic implant and instrument company focused on silicon nitride ceramic technologies, is the first in its’ plan to “become an important platform technology concern in both the spinal and orthopaedic reconstruction markets,” according to the release.
US Spine is a privately held medical device company focused on the development and commercialization of advanced spinal implant systems and its work complements existing spinal implant and device product lines from Amedica, according to the report.
Read the Amedica release on the Amedica acquisition of US Spine (pdf).
Learn more about Amedica.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
